Edwards Lifesciences Corp (NYSE: EW) is 22.52% higher on its value in year-to-date trading and has touched a low of $60.57 and a high of $95.27 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EW stock was last observed hovering at around $93.16 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $93.42, the stock is 3.10% and 10.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.75 million and changing 0.28% at the moment leaves the stock 18.84% off its SMA200. EW registered 15.68% gain for a year compared to 6-month gain of 34.49%. The firm has a 50-day simple moving average (SMA 50) of $9.20 and a 200-day simple moving average (SMA200) of $31.37.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.44% loss in the last 1 month and extending the period to 3 months gives it a 23.20%, and is -0.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.78% over the week and 2.13% over the month.
Edwards Lifesciences Corp (EW) has around 19800 employees, a market worth around $56.17B and $6.00B in sales. Current P/E ratio is 40.59 and Fwd P/E is 30.15. Profit margin for the company is 23.35%. Distance from 52-week low is 54.23% and -1.94% from its 52-week high. The company has generated returns on investments over the last 12 months (19.16%).
Edwards Lifesciences Corp quarterly earnings per share for the current quarter are estimated at $0.64 with sales reaching $1.57B over the same period.The EPS is expected to grow by 9.74% this year, but quarterly earnings will post 8.60% year-over-year. Quarterly sales are estimated to grow 7.90% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1,788 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 84.42% of the company’s shares. The shares outstanding are 601.10M, and float is at 591.80M with Short Float at 1.43%. Institutions hold 83.70% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 52.36 million shares valued at $4.89 billion. The investor’s holdings represent 8.71% of the EW Shares outstanding. As of Dec 30, 2023, the second largest holder is Blackrock Inc. with 52.17 million shares valued at $4.87 billion to account for 8.68% of the shares outstanding. The other top investors are State Street Corporation which holds 26.96 million shares representing 4.48% and valued at over $2.52 billion, while Alliancebernstein L.P. holds 3.17% of the shares totaling 19.09 million with a market value of $1.78 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by BOBO DONALD E JR,the company’sCVP,Strategy/Corp Development. SEC filings show that BOBO DONALD E JR sold 14,500 shares of the company’s common stock on Mar 13 ’24 at a price of $91.01 per share for a total of $1.32 million. Following the sale, the insider now owns 39503.0 shares.
Edwards Lifesciences Corp disclosed in a document filed with the SEC on Mar 11 ’24 that Lemercier Jean-Luc M (CVP, EMEACLA and JAPAC) sold a total of 14,400 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $91.68 per share for $1.32 million. Following the transaction, the insider now directly holds 0.17 million shares of the EW stock.
Still, SEC filings show that on Mar 07 ’24, Lippis Daniel J. (CVP, JAPAC) disposed off 1,715 shares at an average price of $90.98 for $0.16 million. The insider now directly holds 17,213 shares of Edwards Lifesciences Corp (EW).
